Strand Life Sciences secures investment from Quadria Capital

2018-02-09 05:20:32

Strand Life Sciences has secured an investment by Quadria Capital. HealthQuad Fund and Heritas Venture Fund have also contributed to this investment.By Team ABLEBengaluru-based Strand Life Sciences has announced an investment by healthcare focused private equity investor Quadria Capital. India-based HealthQuad Fund and Singapore-based Heritas Venture Fund have also contributed to this fund.Accordi

Read more

Alkem Labs to market Stempeutics\' osteoarthritis stem cell therapy

2018-02-09 05:19:16

Alkem will get the exclusive marketing rights for Stempeucel and Stempeutics will manufacture and supply the product.By Team ABLEAlkem Laboratories has signed an exclusive licensing deal to market the osteoarthritis (OA) therapy Stempeucel, manufactured by Stempeutics Research.As per the agreement, Alkem will get the exclusive marketing rights for Stempeucel and Stempeutics will manufacture and su

Read more

HealthAsyst joins GE Healthcare\'s Centricity Partner Program

2018-02-09 05:17:23

With this partnership, CheckinAsyst, the patient check-in solution offered by HealthAsyst, will be available for users of GE Healthcare’s Centricity Practice Solution and Centricity Group Management.By Team ABLEHealthAsyst, a healthcare technology solutions provider, has partnered with GE Healthcare through GE Healthcare’s Centricity Partner Program. The program aims to partner with organizati

Read more

Lupin-Yoshindo joint venture company YL Biologics succeeds rheumatoid arthritis drug trials

2018-02-09 05:15:16

YL Biologics, a joint venture between Lupin and Yoshindo, has announced that its phase-III clinical studies on a biosimilar version of Etanercept (YLB113) has met with a successful outcome. By Team ABLEYL Biologics, a joint venture between Lupin and Yoshindo, has announced that its phase-III clinical studies on a biosimilar version of Etanercept (YLB113) has met with a successful outcome. Lupin ha

Read more

NHRC issues notice to Centre and DCGI over study on unapproved antibiotics sale

2018-02-09 05:14:26

The NHRC has issued notices to the Secretary, Union Ministry of Health and Family Welfare, and the Drugs Controller General of India (DCGI) on the sale of unapproved antibiotics. By Team ABLEAccording to a report filed by the Press Trust of India (PTI), the National Human Rights Commission (NHRC) has issued notice to the Centre and the Drug-Control Authority over a study, which claimed that millio

Read more

Health Ministry lays down plan to eliminate AIDS By 2030

2018-02-07 09:21:08

The Government of India has launched a seven year National Strategic Plan on HIV/AIDS and Sexually Transmitted Infection prevention and treatment.By Team ABLE The Minister of State (Health and Family Welfare), Smt Anupriya Patel stated this in a written reply in the Rajya Sabha that there has been a 66% decline in the estimated number of annual new HIV infections in the country from 2000 to 2015,

Read more

BIRAC, Venture Center co-organize two day workshop on ‘Taking Med-Tech Startups Beyond Prototyping’

2018-02-07 09:20:13

The 2-day workshop will focus on some important issues facing Med Tech startups after the prototyping stage – rising money, regulations and IP strategy.By Team ABLEA recent report has suggested healthcare, especially MedTech, as an attractive emerging market in India. This has created a great opportunity for Indian companies to make the most in this domain. Reports also suggest that the Indian h

Read more

DST secretary Prof. Ashutosh takes additional charge as DBT secreatry

2018-02-07 06:08:46

Prof. Ashutosh Sharma, Secretary to the Government of India, Department of Science and Technology has taken additional charge as DBT secretary. Prof. K VijayRaghavan, who was the secretary of DBT from January 2013. Prof. VijayRaghavan handed over the charge on February 05, 2018. Professor VijayRaghavan was instrumental in \nthe establishment of the National Centre for Biological Sciences, and \nst

Read more

Data science is today enabling the pharma industry throw off the shackles of the conventional one-drug-one-target-one-disease model of healthcare innovation

2018-02-06 15:14:22

Excerpts from IHC Annual Lecture by Kiran Mazumdar-Shaw By Team ABLEKiran Mazumdar-Shaw, CMD Biocon Limited and Chairperson, Association of Biotechnology Led Enterprises, delivered the IHC Annual Lecture 2018. A widely anticipated annual event in New Delhi’s cultural calendar, the IHC Annual Lectures in the past has featured leading voices from public life on a wide range of compelling topics. W

Read more

Oraxion signs exclusive Option Agreement with US-based biopharmaceutical company

2018-02-06 15:09:08

The agreement provides the biopharma partner the exclusive option to license its lead asset ORX-301 for the treatment of Niemann-Pick Type C disorder (NPC) and Focal Segmental Glomerulosclerosis (FSGS). By Team ABLEOraxion Therapeutics Inc, a spin-off from Bengaluru-based Aten Porus Lifesciences, has announced that it has entered into an Option Agreement with a US-based biopharmaceutical company.

Read more